Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Adjuvanted vs non-adjuvanted flu vaccine in older adults with chronic conditions

Official title: A Comparative Study on the Immunogenicity and Safety of Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in the Elderly

Run by National Taiwan University Hospital · NCT06676644 · Data updated 2026-11-12

This test tries to see if an adjuvanted flu vaccine gives stronger immune protection and similar safety compared with a standard flu shot in people 65 and older who have chronic medical conditions.

More Elderly (People Aged 65 or More) trials

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment200 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Locations1 site (Taipei)
StatusRecruiting
StartedNovember 21, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedFebruary 24, 2026
Trial IDNCT06676644 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 65 or older with at least one chronic medical condition listed in the protocol who have not yet received a flu vaccine this season and have no contraindication to influenza vaccination.

Probably not a fit

People with a history of severe reactions to influenza vaccines, a current-season influenza vaccination, or other contraindications would not be eligible and would not receive benefit from this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a one-year randomized controlled trial at National Taiwan University Hospital comparing an adjuvanted quadrivalent influenza vaccine (aIIV4) with a non-adjuvanted quadrivalent vaccine (IIV4) in Taiwanese adults aged 65 and older with chronic conditions. The trial measures humoral immunogenicity, cellular immune responses, and records safety and adverse events following vaccination. Key eligibility requires age 65+ with at least one chronic medical condition and excludes those with contraindications or prior influenza vaccination in the current season. Participants receive a single season vaccine and are followed through the influenza season for immune response and safety outcomes.

Why it matters

Potential benefit: If successful, the adjuvanted vaccine could provide stronger protection against influenza and reduce complications in older adults with chronic health conditions.

How similar studies have gone: Adjuvanted influenza vaccines have shown improved immune responses in older adults in prior studies and are recommended by some public health bodies, though local data in Taiwan remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 65 years or above
* Presence of at least 1 chronic medical condition associated with increased risk of complicated influenza, including hypertension, chronic obstructive pulmonary disease (group A, B, E), asthma, congestive heart failure (ACC/AHA stage A, B, C, D), coronary arterial disease, diabetes mellitus, chronic liver disease (Child-Pugh score A, B, C) or chronic kidney disease (stage 1\~4), neuromuscular disorders, hematological or solid organ malignancies, recipient of hematopoietic stem cell transplantation or solid organ transplantation.

Exclusion Criteria:

* Contraindications to influenza vaccination including history of severe adverse event after vaccination, such as anaphylaxis or Guillain-Barré Syndrome, or a severe bleeding tendency
* Prior receipt of influenza vaccination during the current flu season.
* Determination by the Principal Investigator (PI) that the participant is ineligible for enrollment based on clinical assessment.

Where it's running

  • National Taiwan University Hospital
    Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.